1171MO PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

N. Girard, Hans J.M. Smit, Anne Sibille, Fiona McDonald, F. Mornex, Marina Chiara Garassino, Andrea Riccardo Filippi, Solange Peters, John K. Field, Daniel C. Christoph, Rainer Fietkau, Vilde Drageset Haakensen, Jair Bar, C. Chouaïd, Victoria Bray, S. C. Kao, W. Sawyer, A. Allen, Muriel Licour, Pilar Garrido